Position in ARGX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$2,832,481
+$810,419 QoQ
Shares Held
3,053
+10.3% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.44%
of 13F equity value
Holder Rank
#177
of 504 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ARGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CIM, LLC holds $15,323,436 across 7 Biotechnology names. ARGX ranks #3 (18.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | KRYS |
Krystal Biotech, Inc.
|
15,703 | $5,836,334 | |
| 2 | EXEL |
Exelixis, Inc.
|
88,412 | $4,810,496 | |
| 3 | ARGX |
Argenx SE
This page
|
3,053 | $2,832,481 | |
| 4 | CORT |
Corcept Therapeutics Inc
|
6,815 | $592,564 | |
| 5 | HRMY |
Harmony Biosciences Holdings, Inc.
|
13,326 | $485,199 | |
| 6 | STOK |
Stoke Therapeutics, Inc.
|
14,556 | $476,272 | |
| 7 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
584 | $290,090 |
All Filings in ARGX
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,832,481 | 3,053 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $2,022,062 | 2,769 | Shares | Sole | 2026-05-18 | |
| 2025-12-31 | $2,216,744 | 2,636 | Shares | Sole | 2026-02-18 | |
| No filing history on record for this holder in this stock. | ||||||